Cargando…
274 Vasculitic Urticaria Treated with Omalizumab. Case Report
BACKGROUND: Vasculitic urticaria (UV) is a condition characterized by hives lasting more than 24 hours, itchy and burning with residual hyperpigmentation. Histopathology is characterized by leukocytoclastic vasculitis, perivascular infiltrate and fibrin deposits. The incidence is approximately 2%, p...
Autores principales: | Ramírez Del Pozo, María Elena, Martínez Saenz, Nancy Paola, Vera, Javier Gomez, Tiro, Jesus Lopez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization Journal
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512871/ http://dx.doi.org/10.1097/01.WOX.0000412031.62254.da |
Ejemplares similares
-
269 Refractory Chronic Urticaria Treated with Omalizumab
por: Saenz, Martinez, et al.
Publicado: (2012) -
279 Near-Fatal Asthma Treated with Omalizumab
por: Contreras Contreras, Elvia Angelica, et al.
Publicado: (2012) -
281 Use of Monoclonal Antibody Omalizumab in the Treatment of Urticaria Chronic
por: Correa, Jorge Vargas
Publicado: (2012) -
139 Genetic Association Study of the IgE Immunodeficiency in Mexican Population
por: Malpica Cruz, Jose Augusto, et al.
Publicado: (2012) -
275 Efficacy of Omalizumab in the Treatment of Urticaria-Vasculitis Associated to Churg-Strauss Syndrome: A Case Report
por: Varricchi, Gilda, et al.
Publicado: (2012)